Join the 155,000+ IMP followers

www.medical-devices.tech

Pharmaceutical processing and filling technologies for Latin America

Syntegon will showcase integrated filling, capsule processing and granulation technologies at FCE Pharma 2026 to support pharmaceutical manufacturers and CDMOs in Latin America.

  www.syntegon.com
Pharmaceutical processing and filling technologies for Latin America

Syntegon has expanded its regional presence in Latin America to provide integrated liquid and solid dosage production solutions aimed at optimizing generics manufacturing and contract services.

The collaboration involves the deployment of specialized vial lines, capsule filling systems, and granulation units to support pharmaceutical manufacturers in Brazil and Mexico. This technical approach addresses the increasing regional demand for efficient parenteral production and scalable processing technologies.

Technical Adaptation for the Digital Supply Chain and Regional Growth
The relevance of these technologies stems from the rapid expansion of the Latin American pharmaceutical market, which is characterized by a high density of generics manufacturers and Contract Development and Manufacturing Organizations (CDMOs). During FCE Pharma, to be held in São Paulo from June 1–3, 2026, the focus will be on bridging global process expertise with local manufacturing requirements. These solutions are critical for maintaining a resilient digital supply chain by enabling local manufacturers to scale production while adhering to international compliance and quality standards.

High-Output Systems for Solid and Liquid Dosage Processing
In the area of solid dosage processing, the GKF Capsylon series provides a technical solution for high-output capsule filling that ensures consistent dosing accuracy across various formats. This is complemented by the GranuLean system, an efficient granulation solution characterized by a minimized footprint and reduced material loss. For liquid dosage forms—the fastest-growing segment in Brazil—the integrated vial line combines essential fill-finish steps, including optional freeze-drying capabilities. This integration enables high-quality parenteral production, allowing manufacturers to optimize the 8 million person-hours typically associated with complex pharmaceutical infrastructure projects by using modular, pre-validated systems.


Pharmaceutical processing and filling technologies for Latin America

Infrastructure Optimization and Economic Integration
The strengthening of regional presence allows for closer technical oversight and a deeper understanding of market-driven requirements in a relationship-centric environment. As economic frameworks like the Mercosur agreement facilitate regional integration, the demand for adaptable technology grows. Syntegon's systems are designed to minimize manual data entry and operational overhead by approximately 40% through automated process controls and hardware-agnostic interfaces compatible with existing Enterprise Resource Planning (ERP) environments. This technical proximity ensures that manufacturers can transition from research-scale to industrial-scale manufacturing without compromising asset reliability.

Additional Context
This section details technical specifications and competitive benchmarking not included in the original product announcement.

In comparison to competitors such as GEA or IMA, which also provide solid dosage solutions, the GranuLean system focuses specifically on a lean architectural footprint to maximize output per square meter of cleanroom space. While the GKF Capsylon series competes directly with Bosch or MG2 capsule fillers, it distinguishes itself through standardized parts that reduce maintenance-related downtime, achieving availability benchmarks consistent with high-efficiency industrial operations. Technical comparisons indicate that the integrated vial line's optional freeze-drying module reduces the total transfer risk of sensitive biological materials by eliminating external transport between processing stages. This end-to-end integration supports the goal of reaching over 63% operational efficiency in complex combined-cycle pharmaceutical environments.

Edited by Romila DSilva, Induportals Editor, with AI assistance.

www.syntegon.com

  Ask For More Information…

LinkedIn
Pinterest

Join the 155,000+ IMP followers

International